Search

Nike stock price down on forecast cut

Markets

Nikkei 225

33,447.67

▼ -177.86 / -0.53%

SSE Composite

3,031.70

▼ -9.27 / -0.30%

IBOVESPA

125,139.67

▼ -377.60 / -0.30%

Straits Times

3,086.42

▼ -8.39 / -0.27%

BMV IPC

52,418.59

▼ -519.83 / -0.98%

Dow Jones

35,356.14

▼ -34.01 / -0.10%

DAX 30

16,004.87

▼ -24.62 / -0.15%

BSE SENSEX

65,970.04

▼ -47.77 / -0.07%

FTSE 100

7,467.63

▼ -20.57 / -0.27%

JSE Top 40

69,366.89

▼ -295.90 / -0.42%

Last Week’s Highlights

Nike cuts its sales forecasts

Nike has adjusted downward its annual sales projections due to caution in consumer spending and a weaker performance in e-commerce. The company plans to implement a $2 billion savings plan over three years, focused on optimizing product offerings and improving the supply chain. This announcement led to an 11% drop in Nike shares. Persistent pressure in the wholesale business and a slowdown in online sales contributed to this expectation adjustment. Despite the challenges, the company highlights the introduction of new styles, such as the Sabrina 1, LeBron 21, and Tatum 1 sneakers, to stimulate demand. Upcoming launches of lines such as GT Cut, Book 1, and Kobe are expected to drive sales in the coming months. 

Rocket Lab surges on millionaire contract

Shares of Rocket Lab experienced a 15% rise during Thursday’s session, boosted by news that its subsidiary, Rocket Lab National Security, was awarded a significant $515 million contract with a U.S. Government customer. This contract covers the manufacture and operation of 18 space vehicles. Despite recent challenges, such as a mission postponement in September that impacted third-quarter revenue and gross margin, Rocket Lab has achieved notable milestones, such as the successful launch of the 42nd Electron rocket. Although shares at a penny have experienced fluctuations, Wall Street analysts are bullish, backing the company with a Strong Buy consensus rating and a median price target of $8.20, suggesting an upside potential of 85.10% from current levels. With a strong track record and outlook for quarterly improvement, Rocket Lab is favorably positioned to deliver stronger financial results soon. 

Coming Up This Week

Karuna shares jump on buyout deal

Bristol Myers Squibb has agreed to acquire Karuna Therapeutics for $14 billion, marking a strategic move to strengthen its drug portfolio in the face of patent expirations on older therapies. The focus falls on Karuna’s experimental drug KarXT, intended for the treatment of schizophrenia, which is expected to drive sales in the late 2020s and into the next decade. This innovative antipsychotic activates muscarinic receptors in the central nervous system, providing therapeutic benefits without the adverse effects common to current antipsychotics. Bristol Myers CEO Chris Boerner highlights expansion opportunities in current and emerging therapeutic areas, such as neuroscience. The acquisition is being made for $330 per share in cash, representing a 53.4% premium, and the deal is expected to affect Bristol Myers’ earnings in the coming years positively. This strategic move follows Bristol Myers’ recent acquisition of Mirati Therapeutics, consolidating its position in the pharmaceutical market. 

Tesla’s battery plant in Shanghai

Tesla is moving forward with construction of its mega-battery plant in Shanghai, China, after acquiring a 19.7-hectare parcel of land for approximately $31.1 million, according to Reuters reports. The strategic location near the existing Model 3 and Model Y vehicle plants will allow for efficient production integration. The battery plant, which is scheduled for completion in the fourth quarter of 2024, is expected to have the capacity to produce 10,000 megapacks per year. This development comes amid Panasonic Energy’s withdrawal of plans to establish a new battery plant in Oklahoma, while BYD, the Chinese electric vehicle giant, expands its global presence with plans for a new factory in Hungary. Despite recent concerns about vehicle defects and challenges in Norway, Tesla shares have experienced a 103% gain over the past year, maintaining a moderate buy consensus valuation, with a median price target of $247.39, indicating a 2.8% downside potential. 

All information provided was collected up to the last business day of the previous week of the release of this NewsFlight. The purpose of NewsFlight is to summarize and make accessible information on a variety of topics within the world of investing and personal finance, and thus cannot be considered formal research or reports. All sources utilized to compile the NewsFlight newsletter are considered trustworthy by the FlexInvest team. FlexInvest is not affiliated with and does not receive remuneration from the news sources used to compile NewsFlight. As well, any images or logos incorporated into the NewsFlight newsletter are not necessarily property of FlexInvest and may solely be included to provide context for the news covered. NewsFlight should not be taken as advice to sell or buy securities or to make any investment. When investing in securities or other financial products, there is always the potential to lose money or asset value. FlexInvest recommends that its users consider their investment objectives and risks before investing. Additionally, any projections or analysis made by authors of NewsFlight cannot be considered as a promise of future trends or returns. Opinions expressed in NewsFlight are not representative of FlexInvest.

Market News

On Friday, the S&P 500 index closed higher amid fluctuations in the main U.S. stock markets, marking an end to the week ahead of the Christmas holidays. Investors assessed inflation data that turned out to be more moderate than anticipated, reinforcing expectations of possible interest rate cuts by the Federal Reserve in the coming year.

Although the Dow Jones, S&P 500 and Nasdaq indices showed some indecision throughout the day, the S&P 500 managed a gain of 7.88 points, or 0.17%, closing at 4,754.63, while the Dow Jones fell slightly by 0.05% and the Nasdaq Composite experienced a small increase of 0.19%.

Wild Card

Buffett’s Berkshire ramps up stake in Occidental stock.

More things to sip on...

Apple stock could hit $250, says analyst.
Should Starbucks worry as CosMc’s enters the market?
Adobe dips post-earnings and presents an opportunity.

Latest Market Insights